	US 12,070,482 B2
	Curcumin compositions and methods of use as an NK3 antagonist
James R. Komorowski, Trumbull, CT (US); and Sarah Sylla, Brooklyn, NY (US)
Assigned to Bonafide Health, LLC, Harrison, NY (US)
Filed by Bonafide Health, LLC, Harrison, NY (US)
Filed on Sep. 1, 2023, as Appl. No. 18/241,567.
Application 18/205,792 is a division of application No. 17/968,788, filed on Oct. 18, 2022, granted, now 11,857,594.
Application 18/241,567 is a continuation of application No. 18/205,792, filed on Jun. 5, 2023, granted, now 11,779,627.
Claims priority of provisional application 63/278,989, filed on Nov. 12, 2021.
Prior Publication US 2023/0414696 A1, Dec. 28, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 36/00 (2006.01); A61K 31/26 (2006.01); A61K 36/82 (2006.01); A61K 36/9066 (2006.01); A61P 15/12 (2006.01)

CPC A61K 36/9066 (2013.01) [A61K 31/26 (2013.01); A61K 36/82 (2013.01); A61P 15/12 (2018.01)]

30 Claims

1. A dietary supplement comprising an amount of a curcumin composition, an amount of a green tea extract composition, and an amount of a phycocyanin composition, wherein the amount of the curcumin composition, the amount of the green tea extract composition, and the amount of the phycocyanin composition comprise a synergistic ratio.